Yuvraj

Bristol-Myers Squibb reports fourth quarter financial results

Bristol-Myers Squibb Company has announced results for the fourth quarter of 2012 highlighted by regulatory approvals for Eliquis and Forxiga. ...

Amgen’s full year 2012 revenues increased 11 percent to $17.3 billion

Amgen has announced financial results for the fourth quarter and full year of 2012. Key results include: For the...

Stellar Biotechnologies develops aquaculture system for KLH manufacturing

Stellar Biotechnologies has developed a controlled, commercial-scale aquaculture system for fully sustainable Keyhole Limpet Hemocyanin (KLH) manufacturing. The land-based...

Synthon opens new GMP antibody-drug conjugate production facility in Nijmegen

Synthon Biopharmaceuticals has opened a GMP antibody-drug conjugate (ADC) production facility in Nijmegen. The Nijmegen facility will produce ADCs,...

New drug protects against side effects of chemotherapy

A drug developed at Linköping University in Sweden protects against the side effects of cancer treatments while strengthening the effects on the tumour....

Takeda establishes new trading company and reinforces business structure in China

Takeda Pharmaceutical Company Limited ("Takeda") today announced the launch of a new trading company in China, Takeda (China) International Trading Co., Ltd. ("TCIT"),...

CSL Behring begins pediatric Phase III hemophilia B study of rIX-FP

CSL Behring has commenced the patient enrollment in pivotal pediatric Phase III hemophilia B study of recombinant fusion protein linking coagulation factor IX...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read